Caption Management, LLC Iveric Bio, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $1.23 Million - $1.61 Million	-65,700 Reduced 51.05%	63,000 $1.53 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $34.2 Million - $47.5 Million	-1,984,800 Reduced 93.91%	128,700 $2.76 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $15.4 Million - $30.4 Million	1,637,200 Added 343.73%	2,113,500 $37.9 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $548,112 - $1.14 Million	60,100 Added 14.44%	476,300 $4.58 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $5.06 Million - $7 Million	416,200 New	416,200 $7.01 Million

Q4 2021 Feb 11, 2022	SELL	$13.83 - $18.78 $4.93 Million - $6.7 Million	-356,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $2.52 Million - $6.24 Million	356,500 New	356,500 $5.79 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.